GLPG-0974
- Generic Name
- GLPG-0974
- Drug Type
- Small Molecule
- Chemical Formula
- C25H25ClN2O4S
- CAS Number
- 1391076-61-1
- Unique Ingredient Identifier
- X7REK61AIS
- Background
GLPG-0974 is under investigation in clinical trial NCT01721980 (Multiple Ascending Dose Study of GLPG0974 in Healthy Subjects).
Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis
- First Posted Date
- 2013-04-11
- Last Posted Date
- 2014-04-25
- Lead Sponsor
- Galapagos NV
- Target Recruit Count
- 45
- Registration Number
- NCT01829321
- Locations
- 🇱🇻
Rīgas slimnīca Bikor Holim, Riga, Latvia
🇨🇿Fakulnà nemocnice Olomouc, Olomouc, Czech Republic
🇱🇻Latvijas Jūras Medicīnas Centrs, Riga, Latvia
Multiple Ascending Dose Study of GLPG0974 in Healthy Subjects
- First Posted Date
- 2012-11-06
- Last Posted Date
- 2013-02-12
- Lead Sponsor
- Galapagos NV
- Target Recruit Count
- 32
- Registration Number
- NCT01721980
- Locations
- 🇧🇪
SGS LSS Clinical Pharmacology Unit Antwerp, Antwerp, Belgium
First-in-Human Exploratory Single Ascending Dose of GLPG0974
- First Posted Date
- 2011-12-21
- Last Posted Date
- 2012-04-19
- Lead Sponsor
- Galapagos NV
- Target Recruit Count
- 32
- Registration Number
- NCT01496937
- Locations
- 🇧🇪
SGS Stuivenberg, Antwerp, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath